BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20633667)

  • 1. p38gamma mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation.
    Long DL; Loeser RF
    Osteoarthritis Cartilage; 2010 Sep; 18(9):1203-10. PubMed ID: 20633667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities.
    Long DL; Ulici V; Chubinskaya S; Loeser RF
    Osteoarthritis Cartilage; 2015 Sep; 23(9):1523-31. PubMed ID: 25937027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes.
    Forsyth CB; Pulai J; Loeser RF
    Arthritis Rheum; 2002 Sep; 46(9):2368-76. PubMed ID: 12355484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-127-5p regulates matrix metalloproteinase 13 expression and interleukin-1β-induced catabolic effects in human chondrocytes.
    Park SJ; Cheon EJ; Lee MH; Kim HA
    Arthritis Rheum; 2013 Dec; 65(12):3141-52. PubMed ID: 24022470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis.
    Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD
    Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of the chondrocyte PI-3 kinase-Akt signaling pathway is stimulus dependent.
    Greene MA; Loeser RF
    Osteoarthritis Cartilage; 2015 Jun; 23(6):949-56. PubMed ID: 25659655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1 is required for matrix metalloproteinase 13 production by chondrocytes in response to fibronectin fragments.
    Long DL; Willey JS; Loeser RF
    Arthritis Rheum; 2013 Jun; 65(6):1561-8. PubMed ID: 23460186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes.
    Rasheed Z; Akhtar N; Haqqi TM
    Arthritis Res Ther; 2010; 12(5):R195. PubMed ID: 20955562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes.
    Park SJ; Cheon EJ; Kim HA
    Osteoarthritis Cartilage; 2013 Jul; 21(7):981-9. PubMed ID: 23611898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin fragment-induced expression of matrix metalloproteinases is mediated by MyD88-dependent TLR-2 signaling pathway in human chondrocytes.
    Hwang HS; Park SJ; Cheon EJ; Lee MH; Kim HA
    Arthritis Res Ther; 2015 Nov; 17():320. PubMed ID: 26563875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine-Mediated Redox Regulation of Cell Signaling in Chondrocytes Stimulated With Fibronectin Fragments.
    Wood ST; Long DL; Reisz JA; Yammani RR; Burke EA; Klomsiri C; Poole LB; Furdui CM; Loeser RF
    Arthritis Rheumatol; 2016 Jan; 68(1):117-26. PubMed ID: 26314228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments.
    Del Carlo M; Schwartz D; Erickson EA; Loeser RF
    Free Radic Biol Med; 2007 May; 42(9):1350-8. PubMed ID: 17395008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a induces catabolic signaling and matrix metalloproteinase production in human articular chondrocytes.
    Huang G; Chubinskaya S; Liao W; Loeser RF
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1505-1515. PubMed ID: 28587781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEP-1-GRX-1 Modulates Matrix Metalloproteinase-13 and Nitric Oxide Expression of Human Articular Chondrocytes.
    Hwang HS; Park IY; Kim HA; Choi SY
    Cell Physiol Biochem; 2017; 41(1):252-264. PubMed ID: 28214840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MALAT-1 inhibits apoptosis and matrix metabolism disorder in interleukin-1β-induced inflammation in articular chondrocytes via the JNK signaling pathway.
    Gao GC; Cheng XG; Wei QQ; Chen WC; Huang WZ
    J Cell Biochem; 2019 Oct; 120(10):17167-17179. PubMed ID: 31111559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli.
    Forsyth CB; Cole A; Murphy G; Bienias JL; Im HJ; Loeser RF
    J Gerontol A Biol Sci Med Sci; 2005 Sep; 60(9):1118-24. PubMed ID: 16183949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief report: stress-inducible nuclear protein 1 regulates matrix metalloproteinase 13 expression in human articular chondrocytes.
    Yammani RR; Loeser RF
    Arthritis Rheumatol; 2014 May; 66(5):1266-71. PubMed ID: 24497499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.
    Dunn SL; Wilkinson JM; Crawford A; Le Maitre CL; Bunning RA
    Osteoarthritis Cartilage; 2014 Jan; 22(1):133-44. PubMed ID: 24211233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chondroprotective agent ITZ-1 inhibits interleukin-1beta-induced matrix metalloproteinase-13 production and suppresses nitric oxide-induced chondrocyte death.
    Kimura H; Yukitake H; Suzuki H; Tajima Y; Gomaibashi K; Morimoto S; Funabashi Y; Yamada K; Takizawa M
    J Pharmacol Sci; 2009 Jun; 110(2):201-11. PubMed ID: 19542681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
    Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
    Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.